Clinical TrialID 6703

Transepithelial (Epi-on) Corneal Collagen Crosslinking to Treat Keratoconus and Corneal Ectasia

NCT04905108

Keratoconus|Corneal Ectasia

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
6703
Evidence Id
6703
Core Evidence Id
6703
Source Clinical Trial Id
6690
Herb2 Clinical Trial Id
HBCT006690
Nct Id
NCT04905108
Title
Transepithelial (Epi-on) Corneal Collagen Crosslinking to Treat Keratoconus and Corneal Ectasia
Status
Recruiting
Phase
Phase 3
Study Result
No
Study Condition
Keratoconus|Corneal Ectasia
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Intervention
DRUG: Riboflavin|DRUG: Riboflavin
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Intervention Purpose
Treatment
Gender
All
Age
Child, Adult, Older_Adult
Enrollment
160
Outcome Measure
Maximum keratometry, The change in maximum keratometry (Kmax) from baseline will be evaluated at 12 months for all eyes randomized in group 1 and group 2., 12 months
Sponsor Collaborator
Cornea and Laser Eye Institute
Funded By
OTHER
Location
Cornea and Laser Eye Institute, Hersh Vision Group, Teaneck, New Jersey, 07666, United States
Other Id
TE-CXL-002
Start Date
2021-06-02
Primary Completion Date
2025-06
Completion Date
2025-12
First Posted
2021-05-27
Results First Posted
Last Update Posted
2023-01-04
Study Document
Study Url
https://clinicaltrials.gov/study/NCT04905108
Title Cn
Title En
Transepithelial (Epi-on) Corneal Collagen Crosslinking to Treat Keratoconus and Corneal Ectasia
Bilingual Status
semi_complete